AI Revolutionizing Precision Medicine Growth

The global market for Artificial Intelligence (AI) in Precision Medicine is projected to experience a significant growth rate of 19.2% during the forecast period. This growth is driven by advancements in machine learning (ML) models that are capable of classifying genes into categories such as tumor suppressors, oncogenes, or neutral genes, with successful predictions of known oncogenes and tumor-suppressor genes like TP53 and PIK3CA.
Recent developments highlight the dynamic nature of this field:
– In July 2022, researchers from IIT Madras developed ‘PIVOT’, an AI technology aimed at identifying cancer-causing genes to aid in personalized cancer treatment plans.
– June 2023 saw Illumina Inc. introduce PrimateAI-3D, an AI tool for accurately predicting disease-causing genetic mutations, marking a significant step towards understanding and manipulating the genetic code with AI and high-performance computing.
– Google Cloud, in May 2023, released two AI-powered technologies designed to speed up drug discovery, focusing on predicting protein structure and function, which could revolutionize precision psychiatry and patient care on a global scale.
– October 2022 witnessed a collaboration between Taliaz and Cerba to offer an AI-driven precision psychiatry solution for predicting the effectiveness of depression treatments.
The market report segments the AI in Precision Medicine Market by components (Hardware, Software and Services), treatment areas (Oncology, Neurology, Cardiology, Respiratory), and applications (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine). It also provides a detailed geographical analysis, covering North America, Europe, Asia-Pacific, and the Rest of the World, alongside profiling key players such as Alphabet Inc., AstraZeneca, Atomwise Inc., and others.
Orion Market Research, the publisher of the report, is recognized for its precise reports and comprises a team proficient in market research and consulting services. This report not only sheds light on the current state and future potential of AI in precision medicine but also underscores the pivotal role of AI in advancing healthcare personalization and efficiency.